Tse Ping

Biography

        "Mr. Tse Ping（谢炳先生）, aged 65, is the founder of the Company and now serves as the Chief Executive Officer of the Company. He is responsible for the overall operations of the Group. With more than 24 years of experience in investment and management in the pharmaceutical industry in the PRC, he is currently a director of CT Tianqing, NJCTT, Jiangsu Fenghai, Jiangsu Qingjiang, Qingdao Haier, Qingdao Chia Tai Haier Medicines Co., Ltd., Qingdao Heng Seng Tang Pharmacy Co., Ltd., and Beijing Tide. He is also a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd. and Chia Tai Oversea Chinese Realty Development Co., Ltd. He is also a nonexecutive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited, the shares of which are listed on GEM Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”). Mr. Tse is still a director of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. (“CTQ”), a council member of the Association of Pharmaceutical Biotechnology of China and an honorary professor of Shenyang University of Pharmacy. Within the contemporary pharmaceutical industry, with the leadership by Mr. Tse, Sino Biopharmaceutical Limited has a leading position in the markets of hepatitis medicines and the therapeutic segment of micro-sphere target sustained medicine. CT Tianqing, Beijing Tide and CTQ were ranked the top 100 profit-making enterprises under the National Pharmaceutical Industrial Statistics Annual Report. In November, 2005, the Company was awarded one of the “Best under 1 US Billion enterprises within the Asian Pacific Region” by Forbes Asia. At the first “Capital – Chinese Outstanding Enterprise Achievement Prize” campaign launched by the Capital Magazine, the Company was awarded the “Capital – Chinese Outstanding Pharmaceutical Group Prize” in May, 2006. In January, 2008, Mr. Tse was awarded the prize of “World Outstanding Chinese” in Hong Kong and an honorary Doctor Degree by the University of West Alabama, United States of America. In December, 2008, he was awarded as the “2007/2008 Asian Knowledge Management Association academician” by the Asian Knowledge Management Association. In June, 2010, Mr. Tse was awarded “The Top Ten Most Leading Innovative Persons of the PRC Enterprises in 2010” by the PRC Productivity Society and the PRC Corporation Press. Mr. Tse was a member of the Ninth, Tenth and Eleventh National Committee of the Chinese People’s Political Consultative Conference. He is currently the vice chairman of Association of Chinese Natives Chamber of Commerce in the PRC and the vice chairman of China International Council for the Promotion of Multinational Corporations. Mr. Tse is the father of Miss Tse, Theresa Y Y, the Chairman of the Board, and a first cousin of Mr. Tse Hsin, an Executive Director of the Company. He is also the brother of Ms. Chia Fai and a first cousin of Miss Tse Wun and Mr. Tse Hsuan, Johnny, all being senior management of the Company. "  

Research Interest

Pharmaceutical Biotechnology